---
title: "Nuwellis appoints Dale Brady principal R&D engineer"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295108358.md"
description: "Nuwellis has appointed Dale Brady as its principal R&D engineer. In this role, Brady will support both existing and new product development programs. He brings extensive experience from previous executive leadership positions at Peytant Solutions and Endogenex, where he directed engineering and operations for commercialization and clinical development. Additionally, Brady spent nearly a decade at Osprey Medical leading the development of next-generation cardiovascular technology."
datetime: "2026-08-06T12:34:49.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295108358.md)
  - [en](https://longbridge.com/en/news/295108358.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295108358.md)
generator: "portal-rs"
---

# Nuwellis appoints Dale Brady principal R&D engineer

-   Nuwellis appointed Dale Brady as principal R&D engineer to support existing and new product development programs. \* Brady previously held executive leadership roles at Peytant Solutions and Endogenex, directing engineering and operations for commercialization and clinical development. \* He also spent nearly a decade at Osprey Medical leading next-generation cardiovascular technology development. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nuwellis Inc. published the original content used to generate this news brief on August 06, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [NUWE.US](https://longbridge.com/en/quote/NUWE.US.md)

## Related News & Research

- [Nuwellis enters co-promotion, distribution pact with Atrility for AtriAmp device](https://longbridge.com/en/news/296914542.md)
- [Nuwellis Q2 sales rise on higher U.S. circuit](https://longbridge.com/en/news/295795985.md)
- [Endovia Health Sciences sets interim CEO, COO pay at $300,000 and $275,000 with market-cap bonuses up to $300,000](https://longbridge.com/en/news/297085928.md)
- [Adelphi Metals reports copper at eight locations at Brady Sudbury project in Ontario](https://longbridge.com/en/news/297182421.md)
- [House of Doge files initial beneficial ownership statement showing Much Wow stake of 7.7 million shares](https://longbridge.com/en/news/296949285.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**